The Global Burden of Disease Study Estimates of Brazil's Cervical Cancer Burden.


Journal

Annals of global health
ISSN: 2214-9996
Titre abrégé: Ann Glob Health
Pays: United States
ID NLM: 101620864

Informations de publication

Date de publication:
09 06 2020
Historique:
entrez: 23 6 2020
pubmed: 23 6 2020
medline: 6 7 2021
Statut: epublish

Résumé

Cervical cancer represents an important preventable cause of morbidity and mortality in developing countries such as Brazil. Investigating temporal evolution of a disease burden in the different realities of the country is essential for improving public policies. To describe the national and subnational burden of cervical cancer, based on the estimates of the 2017 Global Burden of Disease study. Descriptive study of premature mortality (years of life lost [YLL]) and burden of disease (disability-adjusted life years [DALYs]) associated with cervical cancer among Brazilian women aged 25-64 years, between 2000 and 2017. During the study period, age-standardized incidence decreased from 23.53 (22.79-24.26) to 18.39 (17.63-19.17) per 100,000 women, while mortality rates decreased from 11.3 (11.05-11.56) to 7.74 (7.49-8.02) per 100,000 women. These rates were about two to three times greater than equivalent rates in a developed country, such as England: 11.98 (11.45-12.55) to 10.37 (9.85-10.9), and 3.75 (3.68-3.84) to 2.82 (2.75-2.9) per 100,000 women, respectively. Poorer regions of Brazil had greater rates of the disease; for instance, Amapá State in the Northern Region had rates twice as high as the national rates during the same period. Cervical cancer was the leading cause of premature cancer-related mortality (YLL = 100.69, 91.48-110.61 per 100,000 women) among young women (25-29 years) in Brazil and eight federation units of all country regions except the Southeast in 2017. There was a decrease in the burden of cervical cancer in Brazil from 339.59 (330.82-348.83) DALYs per 100,000 women in 2000 to 238.99 (230.45-247.99) DALYs per 100,000 women in 2017. Although there has been a reduction in the burden of cervical cancer in Brazil, the rates remain high, mainly among young women. The persistence of inequalities between regions of Brazil suggests the importance of socioeconomic determinants in the burden for this cancer.

Sections du résumé

Background
Cervical cancer represents an important preventable cause of morbidity and mortality in developing countries such as Brazil. Investigating temporal evolution of a disease burden in the different realities of the country is essential for improving public policies.
Objective
To describe the national and subnational burden of cervical cancer, based on the estimates of the 2017 Global Burden of Disease study.
Methods
Descriptive study of premature mortality (years of life lost [YLL]) and burden of disease (disability-adjusted life years [DALYs]) associated with cervical cancer among Brazilian women aged 25-64 years, between 2000 and 2017.
Findings
During the study period, age-standardized incidence decreased from 23.53 (22.79-24.26) to 18.39 (17.63-19.17) per 100,000 women, while mortality rates decreased from 11.3 (11.05-11.56) to 7.74 (7.49-8.02) per 100,000 women. These rates were about two to three times greater than equivalent rates in a developed country, such as England: 11.98 (11.45-12.55) to 10.37 (9.85-10.9), and 3.75 (3.68-3.84) to 2.82 (2.75-2.9) per 100,000 women, respectively. Poorer regions of Brazil had greater rates of the disease; for instance, Amapá State in the Northern Region had rates twice as high as the national rates during the same period. Cervical cancer was the leading cause of premature cancer-related mortality (YLL = 100.69, 91.48-110.61 per 100,000 women) among young women (25-29 years) in Brazil and eight federation units of all country regions except the Southeast in 2017. There was a decrease in the burden of cervical cancer in Brazil from 339.59 (330.82-348.83) DALYs per 100,000 women in 2000 to 238.99 (230.45-247.99) DALYs per 100,000 women in 2017.
Conclusion
Although there has been a reduction in the burden of cervical cancer in Brazil, the rates remain high, mainly among young women. The persistence of inequalities between regions of Brazil suggests the importance of socioeconomic determinants in the burden for this cancer.

Identifiants

pubmed: 32566484
doi: 10.5334/aogh.2756
pmc: PMC7292105
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

56

Informations de copyright

Copyright: © 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):102-115
pubmed: 28658376
BMC Womens Health. 2017 Apr 12;17(1):30
pubmed: 28403855
Epidemiol Serv Saude. 2018;27(2):e2017285
pubmed: 29742234
Rev Saude Publica. 2014 Jun;48(3):459-67
pubmed: 25119941
Int J Equity Health. 2016 Nov 17;15(1):136
pubmed: 27852313
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
BMC Cancer. 2013 Mar 18;13:127
pubmed: 23506235
Epidemiol Serv Saude. 2017 Jan-Mar;26(1):19-30
pubmed: 28226005
Cad Saude Publica. 2013 Mar;29(3):599-608
pubmed: 23532294
J Hematol Oncol. 2019 Sep 12;12(1):96
pubmed: 31511035
Anticancer Res. 2017 Aug;37(8):4005-4015
pubmed: 28739682
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Epidemiol Serv Saude. 2018 Feb 01;27(1):e20172124
pubmed: 29412351
Hum Reprod. 2018 Jul 1;33(7):1281-1290
pubmed: 29912328
Clin Oncol (R Coll Radiol). 2016 Dec;28(12):766-775
pubmed: 27683104
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Rev Bras Ginecol Obstet. 2019 Apr;41(4):242-248
pubmed: 30847876
Lancet. 2011 May 21;377(9779):1778-97
pubmed: 21561655
Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):1-3
pubmed: 28658368

Auteurs

Nathalia V S Reis (NVS)

Faculdade Ciências Médicas de Minas Gerais, BR.

Brenda B Andrade (BB)

Faculdade Ciências Médicas de Minas Gerais, BR.

Maximiliano R Guerra (MR)

Universidade Federal de Juiz de Fora, BR.

Maria Tereza B Teixeira (MTB)

Universidade Federal de Juiz de Fora, BR.

Deborah C Malta (DC)

Universidade Federal de Minas Gerais, BR.

Valéria M A Passos (VMA)

Faculdade Ciências Médicas de Minas Gerais, BR.
Universidade Federal de Minas Gerais, BR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH